Researchers at the Mass General Brigham Neuroscience Institute have discovered that a specific pattern of brain shrinkage visible on MRI scans can help predict how quickly individuals with early-onset Alzheimer’s disease progress from mild cognitive impairment to dementia, according to findings published in the journal Neurology.
MRI Brain Atrophy Predicts Early-Onset Alzheimer’s Progression
Early-onset Alzheimer’s disease is a rare form of the condition that develops before the age of 65. While this form typically progresses faster than later-onset Alzheimer’s, rates vary widely between individuals, leaving patients, families, and clinicians struggling to anticipate the course of the illness. To address this uncertainty, investigators analyzed data from the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS), a multi-center consortium representing the largest global investigation of early-onset Alzheimer’s disease.
The study evaluated 130 participants aged 40 to 64 who had mild cognitive impairment due to early-onset Alzheimer’s disease, alongside 97 cognitively normal, age-matched control subjects. During an average follow-up period of roughly two years, 84 of the Alzheimer’s participants—about 65 percent—progressed from mild cognitive impairment to full dementia, defined as a loss of memory, language, problem-solving, or other cognitive abilities that disrupts daily life.
Quantitative Measures of Brain Shrinkage Reveal Timeline Risks
By examining baseline MRI scans taken at the start of the study, researchers determined that participants with more pronounced shrinkage in brain regions controlling memory and thinking were significantly more likely to develop dementia sooner than those with less atrophy. As the degree of brain shrinkage increased, the statistical risk of progressing to dementia rose correspondingly. Adding this MRI measurement improved a predictive model that already accounted for age, sex, and baseline cognitive test scores, according to study authors.
Did you know? The Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) is the largest multi-center research consortium in the world specifically dedicated to investigating early-onset Alzheimer’s disease.
“Early-onset Alzheimer’s disease is a challenging diagnosis, worsened by the fact that patients, their caregivers and clinicians don’t know what to expect in the years after the diagnosis,” said co-senior author Alexandra Touroutoglou, PhD, an investigator at the Mass General Brigham Neuroscience Institute, in a statement. “If we can use an MRI that is already part of the diagnostic process to better estimate how quickly someone’s disease may progress, we could help patients and families plan ahead and help clinicians make more personalized decisions about care.”
Co-senior author Mark Eldaief, MD, a neurologist in the Memory Disorders and Frontotemporal Dementia Units at the institute, noted the practical implications for clinical communication. “This study may pave the way to using quantitative measures of brain atrophy in vulnerable brain regions as a way of predicting the timing of functional decline. This is information we haven’t yet been able to give to patients,” Eldaief stated.
Limitations and Future Research Directions
The predictive model was developed and tested primarily in individuals with memory-related mild cognitive impairment. Consequently, researchers caution that these specific findings may not apply as broadly to patients whose early-onset Alzheimer’s disease primarily impacts behavior, language, vision, or spatial skills. Future research will need to validate the MRI measure across diverse populations and investigate whether it successfully predicts critical outcomes such as patient institutionalization or mortality. Subsequent studies may also integrate MRI metrics with amyloid and tau biomarkers to help clinicians identify patients requiring closer clinical oversight and earlier care coordination.
Frequently Asked Questions
What is early-onset Alzheimer’s disease?
Early-onset Alzheimer’s disease is a rare form of the condition that is diagnosed in individuals younger than 65. It typically progresses faster than late-onset Alzheimer’s, though individual rates of progression vary.
How did researchers predict dementia progression in the study?
Researchers analyzed baseline MRI scans from participants and found that greater volume loss or shrinkage in brain regions responsible for memory and thinking correlated with a faster transition from mild cognitive impairment to dementia.
Are these findings applicable to all early-onset Alzheimer’s patients?
Not yet. The current model was tested primarily on individuals with memory-related mild cognitive impairment, meaning further study is required to determine its effectiveness for patients whose symptoms primarily affect language, behavior, or spatial skills.